Might be getting some energy back!

It could very well be the same thing. I chose Survo because the glucagon part of Reta makes me uneasy even though the GLP-1 and GIP receptors have longer safety records from diabetes treatment. I would rather see Reta finish approval and accumulate several years of broad use like Tirzepatide has before trying it myself. Most reports say the tiredness fades between six months and a year, so the small Survo dose seemed like a reasonable bridge. KLOW does appear to give a tiny bit more alertness after the shot, and the SS-31 part feels stronger, but I caution against building a big stack without knowing which piece actually helped.

I get the caution. Phase 3 data from a big company makes me willing to move ahead, though I might still try Survo later on.

I raised my Tirz by only half a milligram each step. Jumping the way you did would leave me barely functional. The tiredness did fade after a few months for me and I have felt fine for about a year now. Methylated B12 made a noticeable difference.

I started right after you, on August 7th. Now at 10 mg I actually have more energy than I have felt in years and have lost 60 pounds, though most of that energy goes into cleaning rather than old hobbies. I have not noticed the fatigue or loss of pleasure others describe. My main issues are stomach pain and loose stools after eating poorly or too much. I have thought about trying NAD but have never used Survo or even heard of it before. Your stack does sound quite loaded.

I began in August 2024. Did you really start in August 2025 and already reach 10 mg?

Yes, I am someone who eats. I keep raising the dose until I can choose what I eat instead of feeling driven to keep eating. Ten milligrams feels comfortable right now, and newer GLP-1 options will appear anyway. This lines up closely with the official schedule.

I agree it is probably safe and have slowly collected a kit or two to keep on hand. When possible I still favor medications that already have wide general-population experience. Using Survo feels like a small loophole because the dose is tiny and not meant to be long term.

Same here. I avoid going overboard on anything without long track records, but I am open to trying a few.

I feel the same way. As a physician I am surprised I ended up experimenting with phase-3 compounds, yet I talked myself into it because phase 3 seemed acceptable. The grey market path still feels like a blur, and now I have enough Retatrutide, Tirzepatide, and Cagri stocked for seven to ten years.